ANI Pharmaceuticals Reports Second Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
ANI Pharma (ANIP) Misses Q2 EPS by 16c, Revenues Beat
August 6, 2020 9:08 AM EDTANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $0.69, $0.16 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $48.5 million versus the consensus estimate of $46.93 million.
Second Quarter 2020 Financial... More
